Archives for February 8, 2010

← 2010

EU revives GMP for excipients

By Nick Taylor

The EFCG has welcomed the addition of excipient GMP requirements to the draft amendments of the EU falsified medicines directive but warned that deeper analysis is needed to establish which products warrant further regulation.

BioClinica and Cephalon ink data management deal

By Nick Taylor

BioClinica is providing Cephalon with end-to-end clinical data management services and hiring some of the biotech’s staff under a three-year, multi-million dollar deal.

MENA emerging as trial destination says ClinTec CEO

By Gareth Macdonald

Improving healthcare infrastructure across the region and a large treatment-naïve patient population makes the Middle East and North Africa (MENA) an increasingly attractive destination for drug trials says ClinTec CEO Rabinder Buttar.